Dirk Huebner
Direttore Tecnico/Scientifico/R&S presso APTEVO THERAPEUTICS INC.
Posizioni attive di Dirk Huebner
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| APTEVO THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di Dirk Huebner
Precedenti posizioni note di Dirk Huebner
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MERSANA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 27/11/2018 | 30/11/2020 |
Boston Biomedical, Inc.
 Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Corporate Officer/Principal | 01/08/2017 | 01/11/2018 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/08/2017 | 01/08/2017 |
Formazione di Dirk Huebner
| Freie Universität Berlin | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Germania | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| MERSANA THERAPEUTICS, INC. | Health Technology |
| APTEVO THERAPEUTICS INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Boston Biomedical, Inc.
Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Commercial Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Dirk Huebner
- Esperienza